These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Relationship between immunoglobulin production and immortalization by Epstein Barr virus. Tosato G, Blaese RM, Yarchoan R. J Immunol; 1985 Aug; 135(2):959-64. PubMed ID: 2989369 [Abstract] [Full Text] [Related]
8. EBV-transformation of surface IgA-positive human lymphocytes. Steinitz M, Klein G. J Immunol; 1980 Jul; 125(1):194-6. PubMed ID: 6247394 [Abstract] [Full Text] [Related]
9. Ig isotypes produced by EBV-transformed B cells as a function of age and tissue distribution. Miyawaki T, Kubagawa H, Butler JL, Cooper MD. J Immunol; 1988 Jun 01; 140(11):3887-92. PubMed ID: 2836502 [Abstract] [Full Text] [Related]
10. Increased IgA and decreased IgG production by Epstein-Barr virus transformed B cells in culture in IgA nephropathy. Layward L, Allen AC, Harper SJ, Feehally J. Exp Nephrol; 1994 Jun 01; 2(1):24-9. PubMed ID: 8081994 [Abstract] [Full Text] [Related]
11. Patterns of isotype commitment in human B cells: limiting dilution analysis of Epstein Barr virus-infected cells. Stein LD, Ledgley CJ, Sigal NH. J Immunol; 1983 Apr 01; 130(4):1640-5. PubMed ID: 6300231 [Abstract] [Full Text] [Related]
12. Cellular origins of human polymeric and monomeric IgA: intracellular and secreted forms of IgA. Moldoveanu Z, Egan ML, Mestecky J. J Immunol; 1984 Dec 01; 133(6):3156-62. PubMed ID: 6092467 [Abstract] [Full Text] [Related]
13. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines. Mevissen ML, Kwekkeboom J, Goormachtig E, Lindhout E, de Groot C. Hum Antibodies Hybridomas; 1993 Apr 01; 4(2):66-73. PubMed ID: 8390865 [Abstract] [Full Text] [Related]
14. Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populations. Meuer SC, Cooper DA, Hodgdon JC, Hussey RE, Morimoto C, Schlossman SF, Reinherz EL. J Immunol; 1983 Sep 01; 131(3):1167-72. PubMed ID: 6309959 [Abstract] [Full Text] [Related]
15. Effect of breast milk of healthy and allergic mothers on in vitro stimulation of cord blood lymphocytes. Zizka J, Hrdý J, Lodinová-Zádníková R, Kocourková I, Novotná O, Sterzl I, Prokesová L. Pediatr Allergy Immunol; 2007 Sep 01; 18(6):486-94. PubMed ID: 17651385 [Abstract] [Full Text] [Related]
16. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells. Wasik M, Myc A, Matej H, Rudzka L. Arch Immunol Ther Exp (Warsz); 1983 Sep 01; 31(6):871-8. PubMed ID: 6331340 [Abstract] [Full Text] [Related]
17. Immunoglobulin-secreting cells in cord blood: effects of Epstein-Barr virus and interleukin-4. Gudmundsson KO, Thorsteinsson L, Gudmundsson S, Haraldsson A. Scand J Immunol; 1999 Jul 01; 50(1):21-4. PubMed ID: 10404047 [Abstract] [Full Text] [Related]
18. Epstein-Barr virus antibodies in patients with laryngeal and hypopharyngeal cancer. Morshed K, Polz-Dacewicz M, Szymański M, Rajtar B, Ziaja-Sołtys M, Gołabek W. Ann Univ Mariae Curie Sklodowska Med; 2003 Jul 01; 58(2):227-31. PubMed ID: 15323196 [Abstract] [Full Text] [Related]
19. The Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) as stimulating cells in mixed lymphocyte culture (MLC). Wasik M, Matej H, Duś D, Myc A. Arch Immunol Ther Exp (Warsz); 1983 Jul 01; 31(6):879-85. PubMed ID: 6331341 [Abstract] [Full Text] [Related]
20. A protective human monoclonal IgA antibody produced in vitro: anti-pneumococcal antibody engendered by Epstein-Barr virus-immortalized cell line. Steinitz M, Tamir S, Ferne M, Goldfarb A. Eur J Immunol; 1986 Feb 01; 16(2):187-93. PubMed ID: 3007166 [Abstract] [Full Text] [Related] Page: [Next] [New Search]